Drug safety and tolerability in prophylactic migraine treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug safety and tolerability in prophylactic migraine treatment

Published:2015-02-13 Issue:5 Volume:14 Page:667-681
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Vécsei László¹²³,Majláth Zsófia⁴,Szok Délia⁵,Csáti Anett⁴,Tajti János⁵

Affiliation:

1. 1University of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary ; ;

2. 2University of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary

3. 3MTA – SZTE Neuroscience Research Group, Semmelweis u. 6, H-6725 Szeged, Hungary

4. 4University of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary

5. 5University of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14740338.2015.1014797

Reference137 articles.

1. The International Classification of Headache Disorders, 3rd edition (beta version)

2. Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II

3. Epidemiology of headache in a general population—A prevalence study

4. The Prevalence, Impact, and Treatment of Migraine and Severe Headaches in the United States: A Review of Statistics From National Surveillance Studies

5. Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

2. The effectiveness and predictors influencing the outcome of onabotulinumtoxinA treatment in chronic migraine: understanding from diverse patient profiles in a single session;Frontiers in Neurology;2024-06-19

3. Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study;Neurology and Therapy;2024-04-06

4. Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study;Pain and Therapy;2024-03-28

5. Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial;Neurology and Therapy;2023-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3